In January 2022, the NYT article questioned the accuracy of certain prenatal tests offered by Labcorp (LH). On it, $LH fell 5%, losing $1...

$ASRT stockholder filed a claim vs. Assertio, its CEO & CFO for overstating the true potential of the Spectrum deal, which led to shareho...

The SEC alleged that TruCrowd failed to conduct due diligence in the crowdfunding offerings, exposing investors to fraud. Specifically,...

In June 2023, Wiley revealed a 6% revenue decrease after the suspension of the publishing program with subpar material. On it, $WLY fell...

In May 2023, a newspaper reported the FBI-assisted execution of a DHS search warrant at the JinkoSolar site. On it, $JKS fell 8.3%, losi...

In October 2022, Instil announced pausing enrollment in ITIL-168 ongoing clinical trials due to drug shortage. On it, $TIL fell 37.1%, l...

Investors in Maison Solutions' stocks have initiated a claim against $MSS and its executives, alleging misleading IPO statements. In Dec...

In April, Infosys’s Q4’ 22 financial results missed consensus estimates, CEO warned of uncertain environment. On it, $INFY fell 9.8%, los...

In Oct, Hormel updated its strategic priorities long-term forecast, reducing projected sales growth and EPS . On it, $HRL fell 9.8%, losi...

In Nov 2021, Hollysys notified SEC of late annual report filing and replacement of independent auditor. On it, $HOLI fell 29%, losing $35...

In February, report was published alleging Harmony’s several problems with US authorities. On it, $HROW fell 3.2%, losing $18M+ of shareh...

In March, report was published alleging multiple violations related to one of Harmony’s drugs. On it, $HRMY fell 25.8%, losing $626M+ of ...

$EAF stockholder filed a claim vs. GrafTech for hiding setbacks on its Monterrey facility, which involved environmental issues. In Augus...

In May 2022, GoodRx retracted its Y2022 guidance and announced negative revenue impact for Q2’22. On it, $GDRX fell 25.9%, losing $256M+ ...

In Nov 2022, G-III disclosed adverse impact of logistical challenges on its EPS. On it, $GIII fell 44.7%, losing $441M+ of shareholder va...